Intravitreal triamcinolone acetonide for exudative age related macular degeneration

2003496 citationsJournal Articlebronze Open Access

Authors

Abstract

Intravitreal injection of 25 mg of crystalline triamcinolone acetonide merits further study for the treatment of exudative age related macular degeneration.

Topics & Keywords

Retinal Diseases and Treatments Ocular Diseases and Behçet’s Syndrome Glaucoma and retinal disorders

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: British Journal of Ophthalmology

Volume 87, Issue 4, pp. 462-468

DOI: 10.1136/bjo.87.4.462

Field-Weighted Citation Impact: 81.30

Command Palette